Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations.
J Gastrointest Cancer
; 52(2): 407-413, 2021 Jun.
Article
in English
| MEDLINE | ID: covidwho-947062
ABSTRACT
INTRODUCTION:
The safety of upper gastrointestinal cancer patients in the SARS-CoV-2 outbreak is extremely important and most surgeons need to establish a contingency management.AIM:
In this study, we present the surgical outlines of patients suffering from upper gastrointestinal cancers. MATERIALS ANDMETHODS:
Data were obtained from PubMed, Cochrane Database of Controlled Trials, and SCOPUS of reports up to September 2020.RESULTS:
The COVID-19 outbreak makes surgical procedures extremely difficult to be performed. The most common criteria to prioritize patients for surgical treatment are stage, tumor biology, presence of tumor-related symptoms, the risk of tumor to become non-resectable, and time interval from neoadjuvant therapy. The multidisciplinary teams can help assigning a priority level to each clinical case.CONCLUSION:
We have to continue providing treatment to oncologic patients in the face of COVID-19 uncertainty, with higher caution and responsibility in order to develop a safer and more effective personalized treatment plan.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Endoscopy, Gastrointestinal
/
Gastrointestinal Neoplasms
/
SARS-CoV-2
/
COVID-19
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Reviews
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Gastrointest Cancer
Year:
2021
Document Type:
Article
Affiliation country:
S12029-020-00557-y
Similar
MEDLINE
...
LILACS
LIS